Related Experiment Video
Updated: May 28, 2026

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo
Published on: August 4, 2018
Epinephrine plus argon plasma or heater probe coagulation in ulcer bleeding
Ahmet Karaman1, Mevlut Baskol, Sebnem Gursoy
1Department of Gastroenterology, Erciyes University, 38030 Kayseri, Turkey. drkaraman@hotmail.com
Argon plasma coagulation (APC) showed higher initial success rates for stopping non-variceal upper gastrointestinal bleeding compared to heater probe coagulation (HPC). Further trials are needed to confirm these findings for bleeding peptic ulcers.
Area of Science:
- Gastroenterology
- Endoscopy
- Medical Devices
Background:
- Non-variceal upper gastrointestinal bleeding is a significant clinical concern.
- Effective endoscopic hemostasis is crucial for managing bleeding peptic ulcers.
Purpose of the Study:
- To compare the efficacy of argon plasma coagulation (APC) and heater probe coagulation (HPC) in achieving hemostasis for non-variceal upper gastrointestinal bleeding.
- To evaluate initial hemostasis and rebleeding rates between APC and HPC.
Main Methods:
- A randomized study involving 85 patients with acute gastrointestinal bleeding from gastric or duodenal ulcers.
- Upper endoscopy was performed, with random assignment to either APC or HPC for bleeding control.
- Primary endpoint: initial hemostasis; Secondary endpoint: rebleeding rates.
Main Results:
- Argon plasma coagulation (APC) achieved significantly higher initial hemostasis rates (97.7%) compared to heater probe coagulation (HPC) (81%) (P < 0.05).
- Rebleeding rates at 4 weeks were lower in the APC group (2.4%) than in the HPC group (8.3%), though not statistically significant (P > 0.05).
Conclusions:
- Argon plasma coagulation (APC) is an effective endoscopic hemostatic method for bleeding peptic ulcers.
- Larger multicenter trials are recommended to validate these findings and further establish APC's role.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
